<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "eptifibatide inj VIAL">
<dose><value>180</value>
<value>2</value>
<value>1</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>0.75 mg/mL</value>
<value>2 mg/mL</value>
</strength>
<frequency><value>ONCE</value>
<value>CONTINUOUS</value>
</frequency>
<instruction><value>Loading dose. ( Maximum dose: 22.6 mg)</value>
<value>Administer by continuous infusion, up to 72 hours</value>
<value>Adjust infusion if creatinine greater than 175 - 250 mol/L</value>
<value>Second loading dose administered 10 minutes after first loading dose in patients undergoing PCI. ( Maximum dose: 22.6 mg)</value>
</instruction>
<volume><value>100 mL</value>
<value>10 mL</value>
</volume>
<units><value>mcg/kg</value>
<value>mcg/kg/minute</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Maximum infusion rate: 15 mg/hour</value>
</AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions, Usage guidelines.</value>
</AHSFormularyStatus>
<AHFSName><value>Antithrombotic Agents, Platelet-Aggregation Inhibitors</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>